NYSEARCA:IHI

iShares U.S. Medical Devices ETF Stock Forecast, Price & News

$63.58
-0.08 (-0.13 %)
(As of 08/2/2021 12:00 AM ET)
Add
Today's Range
$63.36
$63.99
50-Day Range
$55.78
$63.66
52-Week Range
$47.25
$63.99
Volume1.23 million shs
Average Volume1.19 million shs
Market Capitalization$8.14 billion
P/E RatioN/A
Dividend Yield1.06%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IHI News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Medical Devices ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer iShares
Fund NameiShares U.S. Medical Devices ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IHI
Inception Date5/1/2006
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkDow Jones US Select Medical Devices Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$8.16 billion
Average Daily Volume$391,963.30
Discount/Premium-0.03%

ETF Expenses

Management Fee0.44%
Other Expenses0.00%
Total Expenses0.44%
Fee Waiver0.00%
Net Expenses0.44%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerLatour Trading

Geographic Exposure of IHI

Currency Exposure of IHI

Sector Exposure of IHI

Industry Exposure of IHI

speech bubbles
speech bubbles











iShares U.S. Medical Devices ETF (NYSEARCA:IHI) Frequently Asked Questions

What stocks does MarketBeat like better than iShares U.S. Medical Devices ETF?

Wall Street analysts have given iShares U.S. Medical Devices ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares U.S. Medical Devices ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iShares U.S. Medical Devices ETF's stock price been impacted by Coronavirus (COVID-19)?

iShares U.S. Medical Devices ETF's stock was trading at $38.3983 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IHI stock has increased by 65.6% and is now trading at $63.58.
View which stocks have been most impacted by COVID-19
.

Is iShares U.S. Medical Devices ETF a good dividend stock?

iShares U.S. Medical Devices ETF pays an annual dividend of $0.68 per share and currently has a dividend yield of 1.06%.
View iShares U.S. Medical Devices ETF's dividend history.

When did iShares U.S. Medical Devices ETF's stock split? How did iShares U.S. Medical Devices ETF's stock split work?

Shares of iShares U.S. Medical Devices ETF split before market open on Monday, July 19th 2021. The 6-1 split was announced on Monday, July 19th 2021. The newly created shares were payable to shareholders after the market closes on Monday, July 19th 2021. An investor that had 100 shares of iShares U.S. Medical Devices ETF stock prior to the split would have 600 shares after the split.

What other stocks do shareholders of iShares U.S. Medical Devices ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares U.S. Medical Devices ETF investors own include NVIDIA (NVDA), PayPal (PYPL), Cisco Systems (CSCO), Visa (V), Verizon Communications (VZ), AbbVie (ABBV), salesforce.com (CRM), The Walt Disney (DIS), Intel (INTC) and The Home Depot (HD).

What is iShares U.S. Medical Devices ETF's stock symbol?

iShares U.S. Medical Devices ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IHI."

Who are iShares U.S. Medical Devices ETF's major shareholders?

iShares U.S. Medical Devices ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (0.10%), Advisor Group Holdings Inc. (0.09%), TruWealth Advisors LLC (0.04%), MA Private Wealth (0.03%), Patton Albertson Miller Group LLC (0.02%) and Intelligence Driven Advisers LLC (0.02%).

Which institutional investors are selling iShares U.S. Medical Devices ETF stock?

IHI stock was sold by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., Advisor Group Holdings Inc., Intelligence Driven Advisers LLC, GWM Advisors LLC, MBE Wealth Management LLC, Cooper Financial Group, Icon Wealth Partners LLC, and Sharkey Howes & Javer.

Which institutional investors are buying iShares U.S. Medical Devices ETF stock?

IHI stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Brookstone Capital Management, Northwest Capital Management Inc, Clear Creek Financial Management LLC, Mattern Wealth Management LLC, Leonard Rickey Investment Advisors P.L.L.C., Chicago Partners Investment Group LLC, and Summit Financial Group Inc..

How do I buy shares of iShares U.S. Medical Devices ETF?

Shares of IHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares U.S. Medical Devices ETF's stock price today?

One share of IHI stock can currently be purchased for approximately $63.58.

How much money does iShares U.S. Medical Devices ETF make?

iShares U.S. Medical Devices ETF has a market capitalization of $8.14 billion.


This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.